The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
October 2025 Tezspire approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for Tezspire to a second disease characterised by epithelial-driven inflammationAstra ...
12h
Becton, Dickinson and Company: A Dividend Idea With Diverse Medtech Portfolio To Meet Future Demand
Becton, Dickinson and Company announced some preliminary fiscal Q4 results recently. Read why I am reaffirming my prior buy ...
Steriline entwickelt mit der RNFM22 eine robotergestützte Abfülllinie für Beximco Pharmaceuticals, die Flaschen und Spritzen ...
As local advocates work to create a syringe exchange program in Evansville, the framework for the whole system is up in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback